4DMOLECULARTHERAPEUTICS.COM KEYWORD DENSITY CHECKER

Total words: 4694 | 2-word phrases: 1220 | 3-word phrases: 1385 | 4-word phrases: 1464

PAGE INFO

Title Try to keep the title under 60 characters (47 characters)
4DMT | Powering The Future Of Genetic Medicines
Description Try to keep the meta description between 50 - 160 characters (141 characters)
4D Molecular Therapeutics designs, develops and commercializes transformative gene therapeutic products for serious unmet medical conditions.
Keywords Meta keywords are not recommended anymore (0 characters)
H1 H1 tag on the page (19 characters)
Powering The Future

ONE WORD PHRASES 625 Words

# Keyword H1 Title Des Volume Position Suggest Frequency Density
1to599.44%
2erik426.72%
3wpcontentuploads4dmtlogosvg426.72%
40406.40%
5and375.92%
6our345.44%
7for325.12%
8we254.00%
9in254.00%
10more243.84%

TWO WORD PHRASES 1220 Words

# Keyword H1 Title Des Volume Position Suggest Frequency Density
1erik allison393.20%
2wpcontentuploads4dmtlogosvg erik211.72%
3read more211.72%
40 0211.72%
50 erik201.64%
6wpcontentuploads4dmtlogosvg 0181.48%
7gene therapy131.07%
8more wpcontentuploads4dmtlogosvg110.90%
94d molecular100.82%
10cystic fibrosis90.74%
11genetic medicine80.66%
12molecular therapeutics70.57%
13click to60.49%
14clinical trial60.49%
15for gene60.49%
16to enable60.49%
17eye disease60.49%
18genetic medicines60.49%
198 202450.41%
20to enabledisable50.41%

THREE WORD PHRASES 1385 Words

# Keyword H1 Title Des Volume Position Suggest Frequency Density
10 0 erik201.44%
2wpcontentuploads4dmtlogosvg 0 0181.30%
30 erik allison181.30%
4read more wpcontentuploads4dmtlogosvg100.72%
5more wpcontentuploads4dmtlogosvg 090.65%
64d molecular therapeutics70.51%
7click to enabledisable50.36%
8january 11 202450.36%
9allison wpcontentuploads4dmtlogosvg erik50.36%
10wpcontentuploads4dmtlogosvg erik allison2024011150.36%
11february 8 202440.29%
12wpcontentuploads4dmtlogosvg erik allison2024020840.29%
13directed evolution to30.22%
148 2024 february30.22%
15gene therapy for30.22%
16settings click to30.22%
172023endpoints read more30.22%
18for 4d molecular30.22%
19to enabledisable google30.22%
20of genetic medicine30.22%
21cystic fibrosis patients30.22%
224dmt and arbor20.14%
23new partnership with20.14%
24eylea use in20.14%
25cuts eylea use20.14%
26therapy cuts eylea20.14%
272024 january 320.14%
28jj’s new partnership20.14%
29gene therapy cuts20.14%
30biotech read more20.14%

FOUR WORD PHRASES 1464 Words

# Keyword H1 Title Des Volume Position Suggest Frequency Density
1wpcontentuploads4dmtlogosvg 0 0 erik181.23%
20 0 erik allison181.23%
3more wpcontentuploads4dmtlogosvg 0 090.61%
4read more wpcontentuploads4dmtlogosvg 080.55%
5february 8 2024 february30.20%
6click to enabledisable google30.20%
7settings click to enabledisable30.20%
8restores cftr lung production20.14%
9and the appointment of20.14%
10fueling plans to enter20.14%
11plans to enter phase20.14%
12to enter phase 320.14%
13biotech read more wpcontentuploads4dmtlogosvg20.14%
14gene therapy cuts eylea20.14%
15partnership with elektrofi enyo20.14%
16therapy cuts eylea use20.14%
17cuts eylea use in20.14%
18eylea use in wet20.14%
19amd patients biotech divulges20.14%
20patients biotech divulges plans20.14%
21pipeline progress and the20.14%
22progress and the appointment20.14%
23the appointment of new20.14%
24cftr lung production in20.14%
25appointment of new cso20.14%
26of new cso and20.14%
27new partnership with elektrofi20.14%
28jj’s new partnership with20.14%
294d710 safe restores cftr20.14%
30safe restores cftr lung20.14%
314dmt and arbor biotechnologies20.14%
32and arbor biotechnologies partnership20.14%
33arbor biotechnologies partnership to20.14%
34medicines for cns diseases20.14%
35january 11 2024 january20.14%
3611 2024 january 320.14%
37lung production in 320.14%
38injections fueling plans to20.14%
39therapy to drop in20.14%
40to drop in eylea20.14%

EXTERNAL LINKS

# URL Whois Check
1https://www.cgtlive.com/view/taylor-cousar-early-efficacy-cystic-fibrosis-gene-therapy#new_tab Whoiscgtlive.com
2 https://www.healio.com/news/ophthalmology/20240617/video-excellent-anatomic-vision-control-seen-with-4d150-at-24-weeks#new_tab Whoishealio.com
3 https://art19.com/shows/rarecast/episodes/44a116d0-da9f-48c9-b610-0375250cd7a6#new_tab Whoisart19.com
4 https://www.biocentury.com/article/651737/vectorized-biologics-are-patients-and-payers-ready-to-swap-biologics-for-gene-therapies#new_tab Whoisbiocentury.com
5 https://www.reuters.com/markets/us/4d-molecular-soars-mid-stage-data-eye-disease-therapy-checks-all-boxes-2024-02-05/#new_tab Whoisreuters.com
6 https://www.fiercebiotech.com/biotech/4dmt-links-gene-therapy-drop-eylea-injections-fueling-plans-enter-phase-3#new_tab Whoisfiercebiotech.com
7 https://endpts.com/4d-molecular-therapeutics-gene-therapy-cuts-eylea-use-in-wet-amd-patients-biotech-divulges-plans-for-pivotal-studies/#new_tab Whoisendpts.com
8 https://www.modernretina.com/view/4dmt-shares-pipeline-progress-and-the-appointment-of-new-cso-and-sab-board-members#new_tab Whoismodernretina.com
9 https://www.americanpharmaceuticalreview.com/1315-News/609906-4DMT-and-Arbor-Biotechnologies-Partnership-to-Develop-Genetic-Medicines-for-CNS-Diseases/#new_tab Whoisamericanpharmaceuticalreview.com
10 https://endpts.com/j-enyo-raises-e39m-arrowheads-450m-offering/#new_tab Whoisendpts.com
11 https://cysticfibrosisnewstoday.com/news/cf-patients-see-quality-life-gains-with-4d-710-gene-therapy-trial/#new_tab Whoiscysticfibrosisnewstoday.com
12 https://markets.businessinsider.com/news/stocks/positive-clinical-trial-results-and-future-prospects-reinforce-buy-rating-for-4d-molecular-therapeutics-an-analysis-by-geulah-livshits-1032770554#new_tab Whoisbusinessinsider.com
13 https://www.ophthalmologytimes.com/view/4dmt-first-patient-enrolled-in-4d-150-phase-2-spectra-pris-clinical-trials#new_tab Whoisophthalmologytimes.com
14 https://endpts.com/astellas-licenses-aav-vector-from-4dmt-for-rare-eye-disease-gene-therapy/#new_tab Whoisendpts.com
15 https://www.fiercebiotech.com/biotech/astellas-paves-back-loaded-biobucks-deal-4dmt-test-eye-disease-gene-therapy-vector#new_tab Whoisfiercebiotech.com
16 https://endpts.com/4dmts-inhalable-gene-therapy-for-cystic-fibrosis-shows-early-positive-signs-in-tiny-group-of-patients/#new_tab Whoisendpts.com
17 https://www.evaluate.com/vantage/articles/news/trial-results/aerow-hits-mark-4d-molecular#new_tab Whoisevaluate.com
18 https://www.biospace.com/article/recode-vertex-and-4dmt-seek-to-help-yet-untreated-cystic-fibrosis-patients-/#new_tab Whoisbiospace.com
19 https://www.nasdaq.com/articles/5-gene-therapy-companies-that-may-transform-the-medical-industry#new_tab Whoisnasdaq.com
20 https://endpts.com/4d-molecular-therapeutics-acquires-asset-from-fortress-biotech-subsidiary/#new_tab Whoisendpts.com
21 https://www.statnews.com/2023/02/03/cystic-fibrosis-new-treatments/#new_tab Whoisstatnews.com
22 https://cysticfibrosisnewstoday.com/news/nacfc2022-gene-therapy-4d-710-restores-cftr-production/#new_tab Whoiscysticfibrosisnewstoday.com